Experts Define New Type 1 Diabetes Control Standards
A new consensus framework establishes performance tiers for fully closed-loop systems to improve patient outcomes.
Updated on Oct. 27, 2026 in Diabetes
Live Poll
Do you trust that new diabetes technology will improve your daily quality of life?
A research group has released a new consensus framework to standardize the performance of fully closed-loop systems for type 1 diabetes management. The system classifies medical devices into four distinct categories based on their ability to maintain glucose levels within a tight range.
Why it matters
This framework shifts focus toward time in tight range, which is more closely tied to preventing microvascular complications than standard measurement metrics. By establishing uniform benchmarks, the research provides a roadmap for assessing the efficacy of emerging diabetes technology.
The framework utilizes a time in tight range (TITR) metric of 70 to 140 mg/dL, requiring a maximum of 1% time below 54 mg/dL. Systems are classified by performance tiers, with Class 1 devices requiring 90% TITR.
The details
The classification system evaluates devices through rigorous testing, including a 30-minute standardized moderate exercise test that requires a two-hour pre-test fast without carbohydrate intake. Beyond glycemic control, developers must also provide validated person-reported outcomes concerning patient quality of life and diabetes distress.
Timeline
October 27, 2026: The consensus framework was officially published.
Health Landscape
This framework serves as a vital evaluation tool for the ongoing phase 3 clinical trials for neural network systems. By setting these benchmarks, the scientific community can better measure if next-generation artificial pancreas technology effectively mitigates microvascular complications.
Patients may eventually see these standardized classifications reflected in device labeling and clinical performance data. This allows users to better understand the precision and reliability of their closed-loop insulin delivery systems.
The takeaway
Patients and providers should look for systems that meet these high-performance tiers to ensure optimal glycemic management. Focusing on time in tight range is a significant step toward reducing long-term health risks associated with diabetes.
Further reading
For more information on the latest advancements, visit the Diabetes section.
Source note: This article includes information reported by Hcplive.
Live Poll
Do you trust that new diabetes technology will improve your daily quality of life?
